Discontinuation report VIVAXIM

Last updated on 2022-06-01 History
Report ID 161652
Drug Identification Number 02248361
Brand name VIVAXIM
Common or Proper name Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 160UNIT 25MCG
Dosage form(s) SUSPENSION SOLUTION SUSPENSION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1.0 mL (single dose) dual chamber syringe
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-05-31
Remaining supply date 2022-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply No supply remaining
Company comments Discontinuation of the manufacturing of this product.
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-06-01 French Compare
v3 2022-06-01 English Compare
v2 2022-06-01 English Compare
v1 2022-06-01 English Compare

Showing 1 to 4 of 4